BRUXISM TREATMENT MARKET ANALYSIS

Regional Analysis

Global Bruxism Treatment Market- Regional Analysis

Among all regions North America region is expected to dominate the market over the forecast period. This is attributed due to the North America hold 37.8% market share and increasing inorganic strategies such as acquisition by key players in the region. For instance, on January 10, 2022, National Dentex Labs, a dental laboratory network company in North America, announced the acquisition of Biotech Dental Prosthetics located in Palm Beach Gardens, Florida. Terms of the acquisition has not been disclosed.

The Europe region is expected to second largest region over the forecast period. Due to increasing research and development activity by key players in the region. For instance, on May 25, 2022, Centre Hospitalier Universitaire Dijon, France, initiated a clinical trial study on Efficacy of Botulinum Toxin A in the treatment of Bruxism-related Symptomatology (Botox). The clinical trial study is currently in phase 3 and actively recruiting volunteers.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa